Home>News>Haxby Group Supports Long COVID Treatment Trial

Haxby Group Supports Long COVID Treatment Trial

22nd March 2022 - 5:00 PM

Haxby Group are helping independent, science-led, charity, Drug Science, recruit patients to look into treatments for Long COVID.

Dr Bradman, GP Partner and research lead said: “Long COVID has caused many of our patients to suffer from really challenging symptoms. We are always happy to help researchers looking for ways to treat this new condition.”

The trial is open to adults over the age of 18 who have been diagnosed with long COVID. More information and contact details to express interest in the trial can be found here.

Facebook icon Twitter icon YouTube icon